Bruton tyrosine kinase inhibitors for chronic lymphocytic leukemia-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Bruton tyrosine kinase inhibitors for chronic lymphocytic leukemia

Published:2021-09-17 Issue:9 Volume:2021 Page:
ISSN:1465-1858
Container-title:Cochrane Database of Systematic Reviews
language:en
Short-container-title:

Author:

Schmelz Jacob¹,Heesen Philip²,Patnaik Anish³,Holder Travis⁴,Lee Hun J⁵,Molony Donald A⁶

Affiliation:

1. Internal Medicine; UT Health San Antonio; San Antonio Texas USA

2. University of Zurich; Zurich Switzerland

3. Department of Internal Medicine; UT-Houston Health Science Center; Houston TX USA

4. Houston Academy of Medicine; The Texas Medical Center Library; Houston USA

5. Department of Lymphoma & Myeloma; MD Anderson Cancer Center; Houston USA

6. Internal Medicine; UT-Houston Health Science Center; Houston TX USA

Publisher

Wiley

Subject

Pharmacology (medical)

Reference39 articles.

1. Calquence prescribing information https://www.azpicentral.com/calquence/calquence.pdf#page=1

2. Rituximab, ofatumumab and other monoclonal anti-CD20 antibodies for chronic lymphocytic leukaemia;Bauer;Cochrane Database of Systematic Reviews,2012

3. A new prognostic classification of chronic lymphocytic leukemia derived from a multivariate survival analysis;Binet;Cancer,1981

4. Agammaglobulinemia;Bruton;Pediatrics,1952

5. Ibrutinib as initial therapy for patients with chronic lymphocytic leukemia;Burger;New England Journal of Medicine,2015

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP